SE9900398L - Ny användning inom transplantationskirurgi - Google Patents

Ny användning inom transplantationskirurgi

Info

Publication number
SE9900398L
SE9900398L SE9900398A SE9900398A SE9900398L SE 9900398 L SE9900398 L SE 9900398L SE 9900398 A SE9900398 A SE 9900398A SE 9900398 A SE9900398 A SE 9900398A SE 9900398 L SE9900398 L SE 9900398L
Authority
SE
Sweden
Prior art keywords
transplantation
new use
transplant surgery
present
islets
Prior art date
Application number
SE9900398A
Other languages
Unknown language ( )
English (en)
Other versions
SE523817C2 (sv
SE9900398D0 (sv
Inventor
Olle Korsgren
William Bennet
Bo Nilsson
Rolf Larsson
Original Assignee
Corline Systems Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corline Systems Ab filed Critical Corline Systems Ab
Priority to SE9900398A priority Critical patent/SE523817C2/sv
Publication of SE9900398D0 publication Critical patent/SE9900398D0/sv
Priority to CA2361949A priority patent/CA2361949C/en
Priority to PCT/SE2000/000223 priority patent/WO2000045837A1/en
Priority to JP2000596956A priority patent/JP2003501346A/ja
Priority to AT00906843T priority patent/ATE348149T1/de
Priority to DE60032346T priority patent/DE60032346T2/de
Priority to AU28399/00A priority patent/AU769063B2/en
Priority to US09/890,936 priority patent/US7981873B1/en
Priority to EP00906843A priority patent/EP1171156B1/en
Publication of SE9900398L publication Critical patent/SE9900398L/sv
Publication of SE523817C2 publication Critical patent/SE523817C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE9900398A 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler SE523817C2 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9900398A SE523817C2 (sv) 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler
EP00906843A EP1171156B1 (en) 1999-02-05 2000-02-04 Isolierte inslen, die insulin-produzierende zellen enthalten, beschichtete mit heparin
AT00906843T ATE348149T1 (de) 1999-02-05 2000-02-04 Isolated islets, comprising insulin producing cells, coated with heparin
PCT/SE2000/000223 WO2000045837A1 (en) 1999-02-05 2000-02-04 Novel use within transplantation surgery
JP2000596956A JP2003501346A (ja) 1999-02-05 2000-02-04 移植手術における新規な使用
CA2361949A CA2361949C (en) 1999-02-05 2000-02-04 Heparin, or heparin conjugate, islets of langerhans
DE60032346T DE60032346T2 (de) 1999-02-05 2000-02-04 Neue Verwendung in der Transplantationsschirugie
AU28399/00A AU769063B2 (en) 1999-02-05 2000-02-04 Novel use within transplantation surgery
US09/890,936 US7981873B1 (en) 1999-02-05 2000-02-04 Use within transplantation surgery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900398A SE523817C2 (sv) 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler

Publications (3)

Publication Number Publication Date
SE9900398D0 SE9900398D0 (sv) 1999-02-05
SE9900398L true SE9900398L (sv) 2000-08-06
SE523817C2 SE523817C2 (sv) 2004-05-18

Family

ID=20414376

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9900398A SE523817C2 (sv) 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler

Country Status (9)

Country Link
US (1) US7981873B1 (sv)
EP (1) EP1171156B1 (sv)
JP (1) JP2003501346A (sv)
AT (1) ATE348149T1 (sv)
AU (1) AU769063B2 (sv)
CA (1) CA2361949C (sv)
DE (1) DE60032346T2 (sv)
SE (1) SE523817C2 (sv)
WO (1) WO2000045837A1 (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0200198D0 (sv) 2002-01-23 2002-01-23 Astrazeneca Ab New use
US20060275274A1 (en) * 2003-03-26 2006-12-07 Daria Onichtchouk Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome
US8153147B2 (en) * 2005-07-01 2012-04-10 Corline Systems Ab Heparin coating of biological tissue
SE530716C2 (sv) * 2006-10-06 2008-08-19 Corline Systems Ab Molekylärt aggregat på ett substrat
CA2792610A1 (en) * 2010-03-12 2011-09-15 The Australian National University Heparan sulfate replacement therapy
PL3821897T3 (pl) 2011-12-22 2022-11-21 Corline Biomedical Ab Środek i sposób leczenia naczyń krwionośnych
WO2017149391A1 (en) * 2016-03-02 2017-09-08 Laboratoire Francais Du Fractionnement Et Des Biotechnologies The use of antithrombin for coating organs during transplantation
EP4688028A1 (en) 2023-03-30 2026-02-11 Corline Biomedical AB A method for providing an improved heparin functionalized surface
EP4688019A1 (en) 2023-03-30 2026-02-11 Corline Biomedical AB Heparin-functionalized surface, method for its preparation and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135916A (en) 1989-06-12 1992-08-04 Oklahoma Medical Research Foundation Inhibition of complement mediated inflammatory response
CA2067235A1 (en) * 1989-10-12 1991-04-13 David J. G. White Modified biological material
SE470006B (sv) * 1991-09-26 1993-10-25 Corline Systems Ab Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet
EP0610441A4 (en) * 1991-10-29 1996-01-10 Clover Cons Ltd CROSSLINKABLE POLYSACCHARIDES, POLYCATIONS AND LIPIDS CAN BE USED TO ENCODE AND DISPENSE MEDICINAL PRODUCTS.
EP0641222B1 (en) 1992-05-21 2000-09-06 Diatide, Inc. TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING
JP2000500121A (ja) 1995-09-27 2000-01-11 エモリー・ユニバーシティー 免疫系による生きた被移植細胞の破壊を阻止する方法
DE19623440A1 (de) * 1996-06-12 1997-12-18 Wagner Karl Heinz Dr Med Immobilisiertes organisches Material mit definiertem Wirkstoff-Release
US6423316B1 (en) * 1997-03-26 2002-07-23 Imperial College Innovative Limited Anticoagulant fusion protein anchored to cell membrane

Also Published As

Publication number Publication date
US7981873B1 (en) 2011-07-19
AU769063B2 (en) 2004-01-15
EP1171156B1 (en) 2006-12-13
CA2361949A1 (en) 2000-08-10
SE523817C2 (sv) 2004-05-18
JP2003501346A (ja) 2003-01-14
ATE348149T1 (de) 2007-01-15
EP1171156A1 (en) 2002-01-16
DE60032346T2 (de) 2007-07-19
DE60032346D1 (en) 2007-01-25
AU2839900A (en) 2000-08-25
SE9900398D0 (sv) 1999-02-05
CA2361949C (en) 2010-08-03
WO2000045837A1 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
TW200621257A (en) Pyrimidine derivative fused with nonaromatic ring
WO2009023718A3 (en) Novel activators of glucokinase
CN105979975A (zh) 医疗敷料
SE9900398L (sv) Ny användning inom transplantationskirurgi
Liang et al. Lipid rescue of massive verapamil overdose: a case report
EP1454641A3 (en) Porous implantable medical device seeded with mammalian cells
EP2762480A1 (en) Oxazolidinone antibiotics containing fused ring
AR018717A1 (es) COMPUESTOS DERIVADOS DE PIPERIDINA, SU USO, UN PROCESO PARA SU PREPARACIoN, COMPOSICIONES FARMACÉUTICAS QUE LOS COMPRENDEN, Y COMPUESTOS INTERMEDIARIOS.
RU2009110273A (ru) Способ уменьшения повреждения нервных клеток
ATE290396T1 (de) Neue verwendung von hypoosmotischen salinelösungen und darauf basierendem medikament
WO2005103687A3 (en) System and method for providing optimal concentrations for medication infusions
NO20052505L (no) Ny bruk av dextran-sulfat
BR0306798A (pt) Uso de melagatran ou de um derivado farmaceuticamente aceitável deste, métodos de tratamento de diabetes mellitus tipo i, de transplante de células de enxertamento de ilhotas de langerhans, para melhorar a independência de insulina em pacientes com diabetes mellitus tipo i, e de tratamento de reação inflamatória mediada pelo sangue instantânea, formulação farmacêutica para uso no tratamento de diabetes mellitus tipo i, kit de partes, e, método de fabricação de um kit de partes.
Orban et al. Erythromycin-induced cardiac toxicity
Xie et al. Biomaterial-mediated strategies for accurate and convenient diagnosis, and effective treatment of diabetes: advantages, current progress and future perspectives
CA2593171A1 (en) Pharmaceutical composition and method for neoangiogenesis/revascularization useful in treating ischemic heart diseases
ATE493127T1 (de) Verwendung von levo-ornidazol zur herstellung eines antiparasitären infektionswirkstoffs
EA199900510A1 (ru) Инъекционное лекарственное средство "цитофлавин", обладающее цитопротекторным действием
Wallenborn et al. Intensive care in a patient with toxic epidermal necrolysis
CO5611170A2 (es) Uso de un inhibidor antagonista contra el factor tisular
CN112209834B (zh) 一种有机亚硝酸根供体及其制备方法与医药用途
KR101823205B1 (ko) 약물을 봉입한 이식 치료용 세포 클러스터 및 이의 제조방법
CN206434601U (zh) 一种新型辣椒碱水凝胶贴剂
KR20080061431A (ko) 에이디피-라이보실 사이클레이즈 억제제를 이용한 고혈압 및 당뇨병성 신증의 치료제
CN101474178A (zh) 盐酸戊乙奎醚在制备治疗心源性休克疾病药物中的应用

Legal Events

Date Code Title Description
NUG Patent has lapsed